UPC Analytics
DEEN
Übersicht · Eingereicht:

APL_64374/2024

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

BerufungenHauptberufungCourt of AppealAppeal RoP220.1
Parteien

Kläger

  • Insulet Corporation
Vertreter: Frank Peterreins (Peterreins Schley)

Beklagte

  • EOFLOW Co., Ltd.
Vertreter: Mirko Weinert (HOYNG ROKH MONEGIER)
Richter
  • Rian KaldenPresiding Judge
  • Ingeborg SimonssonLegally Qualified Judge
  • Patricia RombachLegally Qualified Judge and Judge-Rapporteur
  • Steven Richard KitchenTechnically Qualified Judge
  • Udo MatterTechnically Qualified Judge
Patente
  • EP4201327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sektor: Packaging & Conveying

Ausgang
PI erteilt
Eingereicht:
Erste Entscheidung: 1. Mai 2025
Sprache:

The Court of Appeal set aside the Milan Central Division's refusal of provisional measures and granted Insulet a pan-European preliminary injunction against EOFlow's insulin pump device ('EOPatch'/'GlucoMen Day Pump'), finding infringement of EP 4 201 327 and awarding costs to Insulet.